Laura J. Meyerson

Laura J. Meyerson

Former Vice President, Biometrics, Biogen

Laura recently retired from Biogen in March 2015 where she was Vice President, Biometrics for 13 years. During her 13-year tenure she led organizations spanning multiple therapeutic areas (neurology, immunology, and oncology) and geographies (U.S. and U.K.). The number of employees in her organization grew dramatically under her direction. She started with less than 50 employees in her department. By the time she left the company in 2015, her staff consisted of approximately 200 employees. Prior to joining Biogen, Laura held several management positions in clinical biostatistics including senior director of biostatistics at Quintiles in Kansas City, and director of biostatistics at Janssen Pharmaceuticals, a J & J company.

Laura started her career in the pharmaceutical industry as a clinical project statistician at Marion Merrell Dow (a legacy company of Sanofi). She has over 30 years' experience in the analysis of clinical trial data for the pharmaceutical industry and has participated as a leader in various professional organizations including the American Statistical Association (ASA), and the Eastern North American Region of the Biometrics Society (ENAR). Laura also participated in PhRMA/EFPIA discussions that led to the recently published Industry Principles for Clinical Trial Data Sharing.

Laura was an assistant professor of statistics in the Department of Operations Research at the Naval Postgraduate School in Monterey prior to joining the pharmaceutical industry. She received her PhD in Biostatistics in 1983, an MA in Biostatistics in 1980, and an AB in Biological Sciences in 1977.